FDA approves first new class of HIV drugs. Food and Drug Administration.
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects; D017277:Drug Approval; D004359:Drug Therapy, Combination; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D019829:Nevirapine; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D011725:Pyridines; D019829:Nevirapine